Hologic, Inc. (HOLX) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $76.01 (—)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 7, 2025 | Vijay Kumar | Evercore ISI | $78.00 | +2.6% |
| May 5, 2025 | Tejas Savant | Morgan Stanley | $65.00 | -14.5% |
| Nov 5, 2024 | Anthony Petrone | Mizuho Securities | $87.00 | +14.5% |
| Oct 4, 2024 | Anthony Petrone | Mizuho Securities | $90.00 | +18.4% |
| Oct 1, 2024 | Patrick Donnelly | Citigroup | $85.00 | +11.8% |
| Jul 30, 2024 | Mike Matson | Needham | $90.00 | +18.4% |
| Jul 2, 2024 | Vijay Kumar | Evercore ISI | $76.00 | -0.0% |
| Jun 27, 2024 | Ian Zaffino | Oppenheimer | $33.00 | -56.6% |
| May 9, 2024 | David Toung | Argus Research | $95.00 | +25.0% |
| Apr 6, 2022 | Vijay Kumar | Evercore ISI | $80.00 | +5.2% |
| Dec 9, 2021 | Anthony Petrone | Jefferies | $95.00 | +25.0% |
| Apr 29, 2021 | Michael Lasser | UBS | $77.00 | +1.3% |
Top Analysts Covering HOLX
HOLX vs Sector & Market
| Metric | HOLX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +3.9% | +1150.3% | +14.9% |
| P/E Ratio | 31.67 | 6.84 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-27 | $4.11B | $4.20B | $4.24B | 12 |
| 2026-12-27 | $1.07B | $1.09B | $1.10B | 3 |
| 2027-03-27 | $1.06B | $1.07B | $1.09B | 5 |
| 2027-06-27 | $1.08B | $1.10B | $1.12B | 5 |
| 2027-09-27 | $1.10B | $1.12B | $1.14B | 5 |
| 2027-12-27 | $1.12B | $1.13B | $1.15B | 5 |
| 2028-03-27 | $1.11B | $1.12B | $1.14B | 2 |
| 2028-06-27 | $1.12B | $1.14B | $1.15B | 2 |
| 2028-09-27 | $1.13B | $1.15B | $1.17B | 2 |
| 2029-09-27 | $4.80B | $4.90B | $4.98B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-27 | $4.28 | $4.42 | $4.56 | 10 |
| 2026-12-27 | $1.10 | $1.12 | $1.14 | 3 |
| 2027-03-27 | $1.13 | $1.16 | $1.18 | 6 |
| 2027-06-27 | $1.20 | $1.22 | $1.25 | 3 |
| 2027-09-27 | $1.27 | $1.30 | $1.32 | 6 |
| 2027-12-27 | $1.22 | $1.24 | $1.27 | 3 |
| 2028-03-27 | $1.23 | $1.25 | $1.28 | 7 |
| 2028-06-27 | $1.25 | $1.28 | $1.31 | 4 |
| 2028-09-27 | $1.35 | $1.38 | $1.41 | 7 |
| 2029-09-27 | $5.58 | $5.75 | $5.87 | 1 |
Frequently Asked Questions
What is the analyst consensus for HOLX?
The consensus among 2 analysts covering Hologic, Inc. (HOLX) is Hold with an average price target of $77.75.
What is the highest price target for HOLX?
The highest price target for HOLX is $95.00, set by David Toung at Argus Research on 2024-05-09.
What is the lowest price target for HOLX?
The lowest price target for HOLX is $33.00, set by Ian Zaffino at Oppenheimer on 2024-06-27.
How many analysts cover HOLX?
2 analysts have issued ratings for Hologic, Inc. in the past 12 months.
Is HOLX a buy or sell right now?
Based on 2 analyst ratings, HOLX has a consensus rating of Hold (3.00/5) with a +3.9% upside to the consensus target of $77.75.
What are the earnings estimates for HOLX?
Analysts estimate HOLX will report EPS of $4.42 for the period ending 2026-09-27, with revenue estimated at $4.20B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.